GEUSENS, Piet

Email Alert RSS Feed

Profile

Full Name
GEUSENS, Piet
Email
piet.geusens@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 341-360 of 446 (Search time: 0.015 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
3412002Double-blind comparison of etanercept and sulfasalazine,alone and combined in patients with active rheumatoid arthritis.Combe, BG; Codreanu, C; Fiocco, U; Gaubitz, M; Kvien, TK; Pavelka, K; Sambrook, PN; Smolen, JS; Williams, BD; Appel, A.M.; GEUSENS, PietJournal ContributionM
3422002Ronde tafel bijeenkomst: preventie en behandeling van glucocorticosteroïd geïnduceerde osteoporoseGEUSENS, Piet; de Nijs, R.N.J.; Bijlsma, J.W.J.; Laan, R.F.J.M.; Lems, W.F.; Struijs, A.; van Staa, T.P.Journal ContributionA3
3432002Epidemiologie van osteoporoseGEUSENS, PietJournal ContributionA3
3442002Anabole therapieën bij osteoporoseGEUSENS, PietJournal ContributionA3
3452002Effect of choline stabilized orthosilicic acid on bone density in chicksMERTENS, Johan; GEUSENS, Piet; Calomme, M.; Wijnen, P.; Sindambiwe, J.; Cos, P.; VAN DEN BERGHE, DavidJournal ContributionA3
3462002Clinical modelling application of finger mathematicalVAN ZWIETEN, Koos Jaap; LIPPENS, Peter; GEUSENS, Piet; Kowalski, M.; Sholukha, V.A.; Zinkovsky, A.V.Journal ContributionA3
3472002The relationship among history of falls, osteoporosis, and fractures in postmenopausal womenGEUSENS, Piet; Autier, P; VANHOOF, Johan; Declerck, K; RAUS, JefJournal ContributionA1
3482002Prevalence of rheumatic diseases in a rheumatological outpatient practiceVANHOOF, Johan; Declerck, K; GEUSENS, PietJournal ContributionA1
3492002A cross-sectional study of treated and untreated postmenopausal women using the IMMULITE (R) automated immunoassay system.Vankrieken, L; Beukeveld, J; Schreurs, C; Dinant, GJ; Durham, AP; El Shami, AS; GEUSENS, PietJournal ContributionM
3502002A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritisGEUSENS, Piet; Truitt, K.; Sfikakis, P.; Zhao, P.L.; DeTora, L.; Shingo, S.; Lau, C.S.; Kalla, A.; Tate, G.Journal ContributionA1
3512002Ankylosing spondylitis is a strong risk factor for vertebral fracturesVosse, D; van der Linden, S; GEUSENS, Piet; VANHOOF, JohanJournal ContributionM
3522002Risedronate reduces the risk of first vertebral fracture in osteoporotic women as soon as 1 year.GEUSENS, Piet; Heaney, R; Chesnut, C; Cros, M; BOS, KimJournal ContributionM
132002Osteoporosis in clinical practice. One-year survey in a rheumatological unitGEUSENS, Piet; VANHOOF, JohanJournal ContributionM
142002Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: Effects of treatment with cyclosporin A (Neoral (R))VANDER BORGHT, Ann; De Keyser, F.; De Backer, M.; Malaise, M.; Baeten, D.; Van den Bosch, F.; Veys, E.M.; GEUSENS, Piet; RAUS, Jef; STINISSEN, PietJournal ContributionA1
152002A simple chart for evaluating risk of osteoporosis based on the Osteoporosis Self-Assessment Tool (OST)GEUSENS, Piet; Pols, H; Siris, E; Hochberg, MC; Ross, PDJournal ContributionM
162002Effects of risedronate on risk of femoral neck and intertrochanteric fracturesAdami, S.; Bensen, W.G.; Miller, Paul D.; Meunier, P; GEUSENS, PietJournal ContributionM
172002Risedronate reduces the risk of first vertebral fracture in osteoporotic womenHeaney, RP; Zizic, TM; Fogelman, I; Olszynski, WP; GEUSENS, Piet; Kasibhatla, C; Alsayed, N.; Isaia, G; Davie, MW; Chesnut, CHJournal ContributionA1
182002Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: A double-blind, placebo-controlled pilot studyBoonen, S; Rosen, C; Bouillon, R; Sommer, A; McKay, M; Rosen, D; Adams, S.; Broos, P; Lenaerts, J; RAUS, Jef; Vanderschueren, D; GEUSENS, PietJournal ContributionA1
192002Performance of risk indices for identifying low bone density in postmenopausal womenGEUSENS, Piet; Hochberg, MC; van der Voort, DJM; Pols, H; van der Klift, M; Siris, E; Melton, ME; Turpin, J; Byrnes, C; Ross, PDJournal ContributionA1
202002Skeletal benefits are maintained through 7 years of alendronate treatmentWeinstein, RS; Meunier, P.J.; Bone, H; Tonino, RP; Ross, PD; Santora, A; GEUSENS, PietJournal ContributionM
show all